Hongyan Tong, Sujun Gao, Wei Yang, Junmin Li, Qingsong Yin, Xingli Zhao, Xiaojing Yan, Sanfang Tu, Fei Li, Haiping Yang, Ronghua Hu, Shaoyuan Wang, Liya Ma, Zheng Dong, Qiying Lu, Wenzhi Tian, Zhi-Jian Xiao, Jianxiang Wang. "Updated results of a phase 2 study: Timdarpacept (IMM01) combined with azacitidine (AZA) as the first-line treatment in adults with chronic myelomonocytic leukemia (CMML).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.6577